3626 results for «346»

Filter By

3626 results

Expanding the spectrum of TEER suitability

18 Feb 2023 – From PCR Tokyo Valves 2023

Join this session to delve into diverse Transcatheter Edge-to-Edge Repair (TEER) scenarios, covering optimal patient groups for MitraClip therapy, insights from the EXPAND G4 study and the meticulous choice of four clip sizes for varying valve anatomies.

Abstracts - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

Outcome of women in different cardiovascular interventions

06 Oct 2022 – From AICT-AsiaPCR 2022

AICT-AsiaPCR 2023 Opening Ceremony

21 Sep 2023 – From AICT-AsiaPCR 2023

This opening ceremony of the 2023 edition of the AICT-AsiaPCR congress provides an opportunity for its Directors and co-Directors to present the programme, of course, but also to offer several prestigious awards, to introduce the Asian Pacific Society of Interventional Cardiology (APSIC) and its missions, and...

AICT-AsiaPCR 2023 Opening Ceremony

POPular TAVI - Antithrombotic Therapy After Transcatheter Aortic Valve Implantation in Patients With a Long-Term Indication for Oral Anticoagulation

04 Apr 2020

The POPular TAVI trial is an open label randomized study designed to evaluate oral anticoagulation (OAC) alone compared with OAC plus clopidogrel for 3 months in patients undergoing transcatheter aortic valve replacement (TAVR) with a long-term indication for oral anticoagulation. Those who had undergone percutaneous revascularization...

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Primary endpoint of All Bleeding

Transcatheter edge-to-edge repair in patients with severe mitral regurgitation and cardiogenic shock: Insights from the TVT Registry

17 Sep 2022

Mirvat Alasnag provides her take on the TEER Shock study which was presented at TCT 2022 by Mohamad A. Alkhouli.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry
Didn’t find what you were looking for?